# Meropenem

NDC: 25021-161
Generic name: Meropenem
Labeler / Manufacturer: Sagent Pharmaceuticals
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, POWDER, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20251101

FDA application: ANDA216424

## Active ingredients

- MEROPENEM: 1 g/30mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"25021-161"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=25021-161
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e8848f4a-bca9-4978-b0a1-38483fd4d639